Medicine and Dentistry
Peritoneal Dialysis
100%
Hemodialysis
47%
Chronic Kidney Disease
36%
End Stage Renal Disease
36%
Bacteremia
31%
Acute Kidney Injury
31%
Cohort Analysis
30%
Fungemia
27%
Albuminuria
24%
Kidney Function
21%
Secondary Hyperparathyroidism
18%
Alfacalcidol
18%
Kidney Graft
17%
Persistent Truncus Arteriosus
16%
Home Hemodialysis
15%
Artery Resistance
13%
Maturity Onset Diabetes of the Young
13%
Glomerular Filtration Rate
13%
Urinary System
13%
Cross Sectional Study
13%
Enzyme Linked Immunosorbent Assay
13%
Mycobacterium antigen
13%
Tuberculin
13%
ANCA Associated Vasculitis
13%
Uremia
13%
Fecal Microbiota Transplantation
13%
Primary Health Care
13%
Pulmonary Hemorrhage
13%
Hemodynamic
13%
Left Ventricular Hypertrophy
13%
Ischemic Preconditioning
13%
Randomized Controlled Trial
13%
Neutrophil Gelatinase Associated Lipocalin
13%
Complex Congenital Heart Disease
13%
Heart Function
13%
Vitamin D Analog
13%
Urinary Tract Infection
13%
Atrasentan
13%
Ischemia
13%
Atypical Hemolytic Uremic Syndrome
13%
Emergency Medical Technician
13%
Heart Failure
13%
Cardiopulmonary Bypass
13%
Central Venous Catheter
13%
Vasodilatation
11%
Peritonitis
11%
Ankle Brachial Index
10%
Contraindication
10%
Infectious Complication
9%
All Cause Mortality
9%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
54%
Congenital Heart Disease
29%
Acute Kidney Failure
29%
Tacrolimus
27%
Ciclosporin
27%
Pharmacokinetics
27%
Normal Human
20%
Hemodialysis
18%
Secondary Hyperparathyroidism
18%
Alfacalcidol
18%
Cohort Study
16%
Enzyme-Linked Immunosorbent Assay
15%
Albuminuria
14%
Cell Culture
13%
Non Insulin Dependent Diabetes Mellitus
13%
Randomized Controlled Trial
13%
Lung Hemorrhage
13%
Immunoassay
13%
ANCA Associated Vasculitis
13%
Placebo
13%
Atrasentan
13%
Buffer
13%
Feces microflora
13%
Heart Left Ventricle Hypertrophy
13%
All Cause Mortality
13%
Pinnipedia
13%
Vitamin D Analog
13%
Neutrophil Gelatinase Associated Lipocalin
13%
Omega-3 Fatty Acid
13%
Urinary Tract Infection
13%
Pregnancy Associated Alpha2 Glycoprotein
13%
Peripheral Occlusive Artery Disease
13%
Focal Glomerulosclerosis
13%
Bacteremia
13%
Fungemia
13%
Abatacept
13%
Paricalcitol
9%
Volume of Distribution
9%
Bioavailability
9%
Elimination
9%
Comorbidity
8%
Blood Vessel Calcification
6%
Glucocorticoid
6%
Proteinuria
6%
End Stage Renal Disease
5%